MJHID Educational Clinical Cases
Vol. 18 No. 1 (2026): Mediterranean Journal of Hematology and Infectious Diseases

Atypical evolution of a Vaso-Occlusive presentation in Sickle Cell Disease: lessons in diagnostic vigilance

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: April 30, 2026
0
Views
0
Downloads
0
HTML

Authors

Acute deterioration following an apparently uncomplicated vaso-occlusive episode in sickle cell disease poses significant diagnostic challenges. When respiratory failure, neurological impairment, and progressive cytopenias develop abruptly, distinguishing between infectious, inflammatory, and thrombotic mechanisms becomes critical.

We describe a 20-year-old woman with sickle cell/thalassaemia admitted for severe limb pain consistent with vaso-occlusion. Within 24 hours, she developed acute respiratory failure, encephalopathy, and thrombocytopenia requiring intensive care support. Initial management targeted presumed sepsis. However, evolving laboratory abnormalities including disproportionate lactate dehydrogenase elevation, extreme hyperferritinaemia, and marked peripheral erythroblastosis without schistocytosis , prompted reconsideration of the differential diagnosis.

Brain magnetic resonance imaging revealed a characteristic pattern supported by futher assessment such as  bronchoalveolar lavage and bone marrow biopsy establishing the final diagnosis.

Treatment with red cell exchange and therapeutic plasma exchange was followed by progressive haematological and neurological recovery.

This case underscores the importance of stepwise diagnostic reasoning in sickle cell disease and highlights how dynamic laboratory interpretation and early referral to specialised centres may be decisive in rare but life-threatening complications.

Downloads

Download data is not yet available.

Citations

1. Zaidi AU, Glaros AK, Lee S, Wang T, Bhojwani R, Morris E, Donohue B, Paulose J, Iorga ŞR, Nellesen D. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease. Orphanet J Rare Dis. 2021;16(1):460.
2. Koehl JL, Koyfman A, Hayes BD, Long B. High risk and low prevalence diseases: Acute chest syndrome in sickle cell disease. Am J Emerg Med. 2022;58:235–244.
3. Tsitsikas DA, Mihalca D, Hall J, May JE, Gangaraju R, Marques MB, Scully M. Pitfalls in diagnosing thrombotic thrombocytopenic purpura in sickle cell disease. J Clin Med. 2022;11(22):6676.
4. Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol.1991;28(3):220–226.
5. Ataga KI, Orringer EP. Bone marrow necrosis in sickle cell disease: A description of three cases and a review of the literature. Am J Med Sci. 2000.
6. Alkindi S, Al-Musalhi M, Pathare A, et al. Fat embolism syndrome in sickle cell disease: A single-centre experience and review of outcomes. Sci Rep. 2025;15:11983.
7. Tsitsikas DA, et al. Bone marrow necrosis and fat embolism syndrome in sickle cell disease. Blood Rev. 2014.
8. Tsitsikas DA, Seligman H, et al. Fat embolism syndrome in sickle cell disease: Pathophysiology and management considerations. J Clin Med. 2020;9(11):3601.
9. Gangaraju R, Reddy VV, Patel K, et al. Fat embolism syndrome due to bone marrow necrosis in patients with sickle cell disease: Diagnostic challenges and therapeutic considerations. Am J Hematol. 2019;94(2):E46–E49.
10. Rizvi S, et al. Bone marrow necrosis and fat embolism syndrome in sickle cell disease during COVID-19 infection treated successfully with sequential red cell andplasmaexchange. eJHaem. 2023.

Ethics Approval

sickle cell disease, fat embolism syndrome, bone marrow necrosis

How to Cite



“Atypical evolution of a Vaso-Occlusive presentation in Sickle Cell Disease: lessons in diagnostic vigilance” (2026) Mediterranean Journal of Hematology and Infectious Diseases, 18(1). doi:10.4084/MJHID.2026.042.